Decompressive Craniectomy for Pediatric Traumatic Brain Injury in Low-and-Middle Income and High Income Countries

Ryan Gidda1, Soham Bandyopadhyay1, Noel Peter1

  • 1Oxford University Global Surgery Group, Nuffield Department of Surgical Sciences, Medical Sciences Division, University of Oxford, Oxford, United Kingdom.

World Neurosurgery
|July 25, 2022
PubMed

Insights

Decompressive craniectomy (DC) may help children with severe traumatic brain injury by reducing intracranial pressure. However, more high-quality, multicenter studies are needed to confirm its effectiveness and improve global treatment consistency.

Area of Science:

  • Pediatric Neurosurgery
  • Neurocritical Care
  • Trauma Surgery

Background:

  • Traumatic brain injury (TBI) is a major cause of death and disability in children globally.
  • Elevated intracranial pressure (ICP) is a primary driver of mortality in severe pediatric TBI.
  • Decompressive craniectomy (DC) is a neurosurgical option for refractory ICP in severe TBI.

Purpose of the Study:

  • To review the current evidence for decompressive craniectomy (DC) in pediatric severe traumatic brain injury (sTBI).
  • To evaluate the efficacy of DC in high-income versus low- and middle-income country settings.
  • To propose improvements in study design for future research on pediatric DC.

Main Methods:

  • This is a narrative review of existing literature on decompressive craniectomy for pediatric severe traumatic brain injury.
  • The review synthesizes evidence from clinical trials, retrospective observational studies, and case series.
  • It critically examines the quality of evidence and discusses methodological limitations.

Main Results:

  • Evidence for DC in pediatric sTBI is limited by conflicting results, few trials, and high risk of bias.
  • Existing research predominantly consists of retrospective studies and case series.
  • The effectiveness of DC may vary between high-income and low- and middle-income country contexts.

Conclusions:

  • Decompressive craniectomy (DC) shows potential as a second-line treatment for pediatric severe traumatic brain injury (sTBI) but requires further investigation.
  • Improved study designs, including larger pediatric cohorts, multicenter collaboration, and standardized methodologies, are crucial.
  • Enhanced research will improve the clinical translatability of findings and optimize outcomes for children with sTBI worldwide.